Research and Markets: European Vitreoretinal Devices Market Projected to Reach $389.9 Million by 2019, New Report Says

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/4ftd64/europe) has announced the addition of the "Europe Vitreoretinal Surgery Devices Market by Types, by End-Users - Analysis and Forecast to 2019" report to their offering.

Vitreoretinal surgery devices are used in the treatment of detached eye retinas. The retina is a crucial and extremely sensitive part of the human eye and is made up of various tissue layers. These tissue layers can be damaged due to various factors, including age-related damage, muscular tears, or severe eye injuries. In accordance with a study conducted by PubMed, it has been found that retinal detachment comprises nearly 5.8% of the total number of cases of vitreoretinal diseases. Moreover, since vitreoretinal diseases are found to be more common in male patients aged 40 years and above, the growing aging population has resulted in an increase in prevalence of these diseases.

Vitreoretinal has continued to remain robust across all regions. This is because the constantly rising diseases associated with eyes in recent years have encouraged the growth of the market. Income has made treatment more affordable. Also there is rise in the geriatric population as well as increase in the number of retinopathies.

The European Vitreoretinal devices market, by type, was valued at $206.9 million in 2014 and is projected to grow at a CAGR of 13.5 % during the forecast period of 2014 to 2019. The market was led by photo-coagulation in 2014, with a 52.8 % share. It is projected to reach a value of $ 194.4 million at a CAGR of 12.2 % through the forecast period. The illumination devices market is estimated to grow at the highest CAGR of 14.6% through 2019. Europe is a key market for vitreoretinal surgery devices. The aging population has been a major segment in terms of application in 2014. Private eye clinics have been the major end-users for this market in 2014.

European Vitreoretinal Surgery Device market is further segmented and forecast on the basis of major countries such as Germany, France, the U.K., Italy, Spain and RoE. Amongst all, Germany accounted for the largest share of 25.4% in the year 2014, with the revenue of $88.9 million, at a CAGR of 9.9% in the forecast period of 2014-2019.

Key Topics Covered

  1. Introduction
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Europe Vitreoretinal Surgery Devices Market, By End-User
  6. Europe Vitreoretinal Surgery Devices Market, By Type
  7. Europe Vitreoretinal Surgery Devices Market, By Geography
  8. Europe Vitreoretinal Surgery Devices Market: Competitive Landscape
  9. Europe Vitreoretinal Surgery Devices Market, By Company (Overview, Financials, Products & Services, Strategy, and Developments)*
  10. Appendix

Companies Mentioned

  • Abbott Laboratories
  • Alcon
  • Allergan
  • Baush & Lomb
  • Carl Zeiss Meditech
  • Essilor Internationals
  • Nidek
  • Topcon

For more information visit http://www.researchandmarkets.com/research/4ftd64/europe

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Medical Devices